Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Molecular Cancer|March 3, 2007
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancerLinda Ulazzi, Silvia Sabbioni, Elena Miotto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocalityLaura Gramantieri, Francesca Fornari, Manuela Ferracin, et al.
Molecular Cancer|August 25, 2007
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancerGiovanni Lanza, Manuela Ferracin, Roberta Gafà, et al.
Blood|June 4, 2011
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemiaRosa Visone, Angelo Veronese, Laura Z Rassenti, et al.
Molecular Cancer|May 28, 2010
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemiaManuela Ferracin, Barbara Zagatti, Lara Rizzotto, et al.
Cancer Research|November 19, 2004
Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancerElena Miotto, Silvia Sabbioni, Angelo Veronese, et al.
Molecular Cancer Research : MCR|December 11, 2013
p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinomaFrancesca Fornari, Maddalena Milazzo, Marzia Galassi, et al.
Oncogene|April 24, 2002
Loss of methylation at chromosome 11p15.5 is common in human adult tumorsRosaria A M Scelfo, Christine Schwienbacher, Angelo Veronese, et al.
Cancer Research|July 9, 2009
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cellsFrancesca Fornari, Laura Gramantieri, Catia Giovannini, et al.
Plos One|November 5, 2020
Air and surface measurements of SARS-CoV-2 inside a bus during normal operationPiero Di Carlo, Piero Chiacchiaretta, Bruna Sinjari, et al.
Pageof 5